HETLIOZ
Live / Registered — Registered and renewed (as of 08 Apr 2024)
What this means for you
Registered since 17 Jun 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Jun 2024).
Record
- Serial number
- 85383242
- Registration number
- 4552099
- Mark type
- Stylized text
- Filed
- 28 Jul 2011
- Published for opposition
- 01 May 2012
- Registered
- 17 Jun 2014
- Next maintenance due
- 17 Jun 2024
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Rockville, MD, US
Prosecution history
- 08 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 08 Apr 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 08 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
- 17 Jun 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Dec 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Dec 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2019 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jun 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2014 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2014 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 09 May 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED